Dr. Gerald Wiegand
Dr. Gerald Wiegand

Dr. Gerald Wiegand

Country Director Germany, Moderna

Day1, July 5, 13:30 p.m., Sesson A:
Innovative techonlogies: How molecular advances could shape the future of medicine

Dr. Gerald Wiegand is leading Moderna's activities in Germany. He has more than 20 years of experience in the life sciences industry and was most recently responsible for the German business unit for rare metabolic diseases at Takeda since 2017. Previously, Gerald Wiegand worked in oncology at Bristol-Myers Squibb and Eli Lilly. He established the German subsidiary of the oncology diagnostics company Genomic Health (now Exact Sciences) and the German professional association of Accredited Laboratories in Medicine (ALM e.V.). Gerald Wiegand holds a PhD in Biophysics from the Technical University of Munich and a MBA from INSEAD.